左心室辅助装置植入后重度二尖瓣反流的可逆性:来自真实患者人群的单中心观察
本研究纳入本中心6年内接受左心室辅助装置(LVAD)治疗的234例患者中,筛选出128例有高质量超声心动图且未行二尖瓣置换或同期二尖瓣修复者,分为重度二尖瓣反流(MR)组(A组,n=65)与无至中度MR组(B组,n=63,其中28例中度MR)。结果显示LVAD植入后MR严重程度显著下降(重度MR术前51% vs 术后6%,P<0.001),两组在右心衰竭、紧急心脏移植率、泵血栓或室性心律失常方面无差异,1年与3年生存率亦无差异。
要点
- LVAD植入后重度MR比例由术前51%降至术后6%,差异有统计学意义(P<0.001)。
- A组与B组在右心衰竭、紧急心脏移植、泵血栓及室性心律失常方面无差异。
- A组与B组1年生存率87.7% vs 88.4%、3年生存率71.8% vs 66.6%,差异无统计学意义(P=0.97)。
核心结论
- 术前重度MR在多数患者中于LVAD植入后早期缓解,且不与更差的临床结局或中期生存相关。
研究设计与样本
- 单中心观察性研究,自6年内本中心接受LVAD治疗的234例患者中筛选128例,分为A组重度MR(n=65)与B组无至中度MR(n=63,其中28例中度MR)。
- 术前经胸超声心动图于LVAD植入前15(7-28)天进行,术后随访至末次可用随访,为LVAD植入后501(283-848)天,数值以中位数(四分位距)表示。
- 排除术前已行二尖瓣置换或LVAD植入时行二尖瓣修复者,并排除超声图像质量不佳者。
主要发现
- LVAD植入后MR严重程度显著下降:重度MR术前51% vs 术后6%,P<0.001。
- 两组在右心衰竭、紧急心脏移植率、泵血栓或室性心律失常方面无差异。
- A组与B组1年生存率87.7% vs 88.4%,3年生存率71.8% vs 66.6%,差异无统计学意义(P=0.97)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study evaluates the impact of untreated preoperative severe mitral valve regurgitation (MR) on outcomes after left ventricular assist device (LVAD) implantation. METHODS: Of the 234 patients who received LVAD therapy in our centre during a 6-year period, we selected those who had echocardiographic images of good quality and excluded those who underwent mitral valve replacement prior to or mitral valve repair during LVAD placement. The 128 patients selected were divided into 2 groups: Group A with severe MR (n = 65) and Group B with none to moderate MR (n = 63, 28 with moderate MR). We evaluated transthoracic echocardiography preoperatively [15 (7-28) days before LVAD implantation; median (interquartile range)] and postoperatively up to the last available follow-up [501 (283-848) days after LVAD]. We collected mortality, complications and clinical status indicators of the patient cohort. RESULTS: We observed a significant decrease in the severity of MR after LVAD implantation (severe MR 51% pre- vs 6% post-LVAD implantation, P < 0.001). There was no difference between groups in terms of right heart failure, rate of urgent heart transplantation, pump thrombosis or ventricular arrhythmias. There was no difference in 1-year survival and 3-year survival (87.7% vs 88.4% and 71.8% vs 66.6% for Groups A and B, respectively, P = 0.97). CONCLUSIONS: Preoperative severe MR resolves in the majority of patients early on after LVAD implantation and is not associated with worse clinical outcomes or intermediate-term survival.
引用
- Dobrovie M, Spampinato RA, Efimova E, et al. Reversibility of severe mitral valve regurgitation after left ventricular assist device implantation: single-centre observations from a real-life population of patients. Eur J Cardiothorac Surg. 2018. PMID: 29351635. doi:10.1093/ejcts/ezx476
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。